search
Back to results

Efficacy of TOCT and (tDCS) for Gait Improvement in Patients With Chronic Stroke

Primary Purpose

Stroke

Status
Completed
Phase
Phase 2
Locations
Italy
Study Type
Interventional
Intervention
sham tDCS + TOCT
real tDCS + TOCT
Sponsored by
University Hospital of Ferrara
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke focused on measuring Chronic Stroke, tDCS, transcranial direct current stimulation, task oriented circuit training, TOCT, gait training

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion criteria:

  • Males and females subjects. Age > 18 years, <75 years.
  • Diagnosis of first ischemic stroke > 6 months.
  • MMSE>24;
  • FAC higher or equal to 4

Exclusion Criteria:

  • Contraindications to tDCS: intracranial metal implants that can be stimulated, incorrectly positioned or over-heated by the electric current, presence of a history of epilepsy, frequent headaches or neck pain, implantable devices (ventriculoperitoneal shunts, pacemakers, intrathecal pumps, intracranial metal implants).
  • Neurological or psychiatric pathology.
  • Severe cardio-pulmonary, renal, hepatic diseases.
  • Pregnancy.

Sites / Locations

  • Ferrara University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

real tDCS + TOCT

sham tDCS + TOCT

Arm Description

Every day will be given continuous stimulation duration of 15 minutes with intensity of 0.5 mA (for a current density of 60μA/cm2), generated by a constant current stimulator rechargeable batteries for 10 consecutive days after any rehabilitation treatment in the gym. Two sponge electrodes are placed, soaked in saline solution, fixed by an elastic band, the anode consists of an electrode oblong 8cm2 positioned at M1 area on the lower limb affection (following the medial sagittal axis, with the center of the electrode positioned at one centimeter laterally to the vertex) while the cathode (48cm2) is placed in the contralateral supraorbitale area as reference electrode. The current reaches 0.5mA and decreases with a ramp of 10 seconds.

Every day will be given a continuous low-intensity stimulation of 0.5mA (for a current density of 60μA/cm2) only for 10 seconds at the beginning and at the end of the stimulation for 10 consecutive days after any rehabilitative treatment. The mounting of electrodes for sham stimulation is the same used for the experimental group.

Outcomes

Primary Outcome Measures

Change from baseline in walking abilities, balance and mobility in Six minutes walking test (6MWT)

Secondary Outcome Measures

10 meter walking test (test of 10m)
walking speed test
Timed "up and go" test (TUG)
Unified Balance Scale (UBS)
Fatigue Severity Scale (FSS)
Stroke Impact Scale (SIS) version 3.0
Stroke Specific Quality of Life (SS-QOL)

Full Information

First Posted
June 14, 2013
Last Updated
December 19, 2014
Sponsor
University Hospital of Ferrara
search

1. Study Identification

Unique Protocol Identification Number
NCT01883843
Brief Title
Efficacy of TOCT and (tDCS) for Gait Improvement in Patients With Chronic Stroke
Official Title
Efficacy of a Task-oriented Circuit Training Associated With Transcranial Direct Current Stimulation (tDCS) for Gait Improvement in Chronic Stroke Patients . A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
December 2014
Overall Recruitment Status
Completed
Study Start Date
May 2013 (undefined)
Primary Completion Date
September 2014 (Actual)
Study Completion Date
September 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital of Ferrara

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Stroke is one of the major causes of disability in the Western world. Initially gait is the most affected function, 80% of patients lose this ability. Rehabilitation in stroke patients improves walking abilities in terms of gait and related gait activities, though six months after stroke many patients are significantly disabled. Recently, a prospective study of 205 stroke patients showed that approximately 21% of patients have a significant decrease of mobility between the first and the third year after stroke. The main finding showed that inactivity was the most important factor for the mobility decline. Evidence about effects of direct current brain stimulation on motor recovery function of lower limb are still little, some show that quadriceps strength after stimulation of damaged M1 area increased. Another study where tDCS was associated with robotic gait training did not report any effect compared to treatment alone. It is necessary to define if a different dosage of stimulation or the association of tDCS with gait training can improve walking and if further studies are required to investigate their effectiveness. The aim of this clinical trial is to test the possibility of gait improvement through the association of tDCS with a specific task-oriented circuit training for walking abilities, balance and mobility.
Detailed Description
Inclusion criteria: Males and females subjects. Age > 18 years, <75 years. Diagnosis of first ischemic stroke > 6 months. Mini mental State Examination (MMSE) >24; Functional Ambulation Classification (FAC) higher or equal to 4

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
Chronic Stroke, tDCS, transcranial direct current stimulation, task oriented circuit training, TOCT, gait training

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
21 (Actual)

8. Arms, Groups, and Interventions

Arm Title
real tDCS + TOCT
Arm Type
Experimental
Arm Description
Every day will be given continuous stimulation duration of 15 minutes with intensity of 0.5 mA (for a current density of 60μA/cm2), generated by a constant current stimulator rechargeable batteries for 10 consecutive days after any rehabilitation treatment in the gym. Two sponge electrodes are placed, soaked in saline solution, fixed by an elastic band, the anode consists of an electrode oblong 8cm2 positioned at M1 area on the lower limb affection (following the medial sagittal axis, with the center of the electrode positioned at one centimeter laterally to the vertex) while the cathode (48cm2) is placed in the contralateral supraorbitale area as reference electrode. The current reaches 0.5mA and decreases with a ramp of 10 seconds.
Arm Title
sham tDCS + TOCT
Arm Type
Active Comparator
Arm Description
Every day will be given a continuous low-intensity stimulation of 0.5mA (for a current density of 60μA/cm2) only for 10 seconds at the beginning and at the end of the stimulation for 10 consecutive days after any rehabilitative treatment. The mounting of electrodes for sham stimulation is the same used for the experimental group.
Intervention Type
Device
Intervention Name(s)
sham tDCS + TOCT
Intervention Description
Every day will be given a continuous low-intensity stimulation of 0.5mA (for a current density of 60μA/cm2) only for 10 seconds at the beginning and at the end of the stimulation for 10 consecutive days after any rehabilitative treatment. The mounting of electrodes for sham stimulation is the same used for the experimental group.
Intervention Type
Device
Intervention Name(s)
real tDCS + TOCT
Intervention Description
Every day will be given continuous stimulation duration of 15 minutes with intensity of 0.5 mA (for a current density of 60μA/cm2), generated by a constant current stimulator rechargeable batteries for 10 consecutive days after any rehabilitation treatment in the gym. Two sponge electrodes are placed, soaked in saline solution, fixed by an elastic band, the anode consists of an electrode oblong 8cm2 positioned at M1 area on the lower limb affection (following the medial sagittal axis, with the center of the electrode positioned at one centimeter laterally to the vertex) while the cathode (48cm2) is placed in the contralateral supraorbitale area as reference electrode. The current reaches 0.5mA and decreases with a ramp of 10 seconds.
Primary Outcome Measure Information:
Title
Change from baseline in walking abilities, balance and mobility in Six minutes walking test (6MWT)
Time Frame
1)A week prior to treatment beginning 2) the week after treatment end 3) three months follow up.
Secondary Outcome Measure Information:
Title
10 meter walking test (test of 10m)
Description
walking speed test
Time Frame
1)A week prior to treatment beginning 2) the week after treatment end 3)three months follow up
Title
Timed "up and go" test (TUG)
Time Frame
1)A week prior to treatment beginning 2) the week after treatment end 3)three months follow up.
Title
Unified Balance Scale (UBS)
Time Frame
1)A week prior to treatment beginning 2) the week after treatment end 3)three months follow up.
Title
Fatigue Severity Scale (FSS)
Time Frame
1)A week prior to treatment beginning 2) the week after treatment end 3)three months follow up.
Title
Stroke Impact Scale (SIS) version 3.0
Time Frame
1)A week prior to treatment beginning 2) the week after treatment end 3)three months follow up.
Title
Stroke Specific Quality of Life (SS-QOL)
Time Frame
1)A week prior to treatment beginning 2) the week after treatment end 3)three months follow up.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion criteria: Males and females subjects. Age > 18 years, <75 years. Diagnosis of first ischemic stroke > 6 months. MMSE>24; FAC higher or equal to 4 Exclusion Criteria: Contraindications to tDCS: intracranial metal implants that can be stimulated, incorrectly positioned or over-heated by the electric current, presence of a history of epilepsy, frequent headaches or neck pain, implantable devices (ventriculoperitoneal shunts, pacemakers, intrathecal pumps, intracranial metal implants). Neurological or psychiatric pathology. Severe cardio-pulmonary, renal, hepatic diseases. Pregnancy.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sofia Straudi, MD
Organizational Affiliation
Ferrara Rehabilitation Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ferrara University Hospital
City
Ferrara
ZIP/Postal Code
44124
Country
Italy

12. IPD Sharing Statement

Citations:
PubMed Identifier
33175411
Citation
Elsner B, Kugler J, Pohl M, Mehrholz J. Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physical and cognitive functioning, in people after stroke. Cochrane Database Syst Rev. 2020 Nov 11;11(11):CD009645. doi: 10.1002/14651858.CD009645.pub4.
Results Reference
derived

Learn more about this trial

Efficacy of TOCT and (tDCS) for Gait Improvement in Patients With Chronic Stroke

We'll reach out to this number within 24 hrs